A real-world analysis of safety profile of selexipag by using FDA adverse event Reporting System (FAERS)

CONCLUSIONS: The findings contribute valuable insights to clinical practice, reinforcing the importance of vigilant monitoring, and can be instrumental in guiding both therapeutic applications and safety assessments of this particular medication.PMID:38032065 | DOI:10.1080/14740338.2023.2290633

Source: Expert Opinion on Drug Safety - November 30, 2023 Category: Drugs & Pharmacology Authors: Jie Zhao Mei Wang Qing Yu Yi Yang Bin Zhang Sanhua Zhan Source Type: research